Regeneron Pharmaceuticals
REGN
REGN
1,320 hedge funds and large institutions have $98.8B invested in Regeneron Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 123 funds opening new positions, 540 increasing their positions, 426 reducing their positions, and 83 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,320
Holders Change
+20
Holders Change %
+1.54%
% of All Funds
19.2%
Holding in Top 10
29
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+16%
% of All Funds
0.42%
New
123
Increased
540
Reduced
426
Closed
83
Calls
$1.09B
Puts
$1.55B
Net Calls
-$465M
Net Calls Change
+$195M
Top Buyers
| 1 |
JPMorgan Chase & Co
New York
|
$8.7B |
| 2 |
Goldman Sachs
New York
|
$724M |
| 3 |
Franklin Resources
San Mateo,
California
|
$2.02B |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
$587M |
| 5 |
UBS AM
Chicago,
Illinois
|
$891M |
